Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents

Autor: Liefke C. van der Heijden, Marlies M. Kok, Paolo Zocca, Hanim Sen, Marije M. Löwik, Silvia Mariani, Frits H. A. F. de Man, Marc Hartmann, Martin G. Stoel, K. Gert van Houwelingen, J. (Hans) W. Louwerenburg, Gerard C. M. Linssen, Carine J. M. Doggen, Jan G. Grandjean, Clemens von Birgelen

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 3 (2018)

BackgroundPercutaneous coronary intervention (PCI) in patients with previous coronary artery bypass grafting (CABG) is associated with adverse clinical events. Although newer generation drug‐eluting stents showed favorable short‐term safety profi

Externí odkaz: https://doaj.org/article/d4b839f1a07e48468123d10dda03d38a

Long-term outcome of consecutive patients with previous coronary bypass surgery, treated with newer-generation drug-eluting stents

Autor: Gerard C.M. Linssen, Marije M. Löwik, Hanim Sen, Liefke C. van der Heijden, K. Gert van Houwelingen, Martin G. Stoel, Marc Hartmann, Frits H.A.F. de Man, Marlies M. Kok, Paolo Zocca, Carine J.M. Doggen, Clemens von Birgelen, Jan G. Grandjean, J. (Hans) W. Louwerenburg, Silvia Mariani

Publikováno v: Journal of the American Heart Association, 7(3):e007212. Wiley-Blackwell
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Background Percutaneous coronary intervention ( PCI ) in patients with previous coronary artery bypass grafting ( CABG ) is associated with adverse clinical events. Although newer generation drug‐eluting stents showed favorable short‐term safety

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71066fc84ae12a63287cadd9d5ffbab3
https://research.utwente.nl/en/publications/ba683ea6-c97d-4f8f-b8a7-ae1172e0c0cf

Comparison of Zotarolimus- and Everolimus-Eluting Coronary Stents Final 5-Year Report of the RESOLUTE All-Comers Trial

Autor: Manuela Negoita, Javaid Iqbal, Henning Kelbæk, Gert Richardt, Paweł Buszman, Patrick W. Serruys, Sigmund Silber, Marie-Angèle Morel, Stephan Windecker

Publikováno v: Circulation-cardiovascular interventions, 8(6). Lippincott Williams & Wilkins
Iqbal, Javaid; Serruys, Patrick W; Silber, Sigmund; Kelbaek, Henning; Richardt, Gert; Morel, Marie-Angele; Negoita, Manuela; Buszman, Pawel E; Windecker, Stephan (2015). Comparison of zotarolimus-and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trial. Circulation: Cardiovascular interventions, 8(6), e002230. Lippincott Williams & Wilkins 10.1161/CIRCINTERVENTIONS.114.002230

Background— Newer-generation drug-eluting stents that release zotarolimus or everolimus have been shown to be superior to the first-generation drug-eluting stents. However, data comparing long-term safety and efficacy of zotarolimus- (ZES) and ever

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0270f13e6439a332211438d140dd6578
https://pure.eur.nl/en/publications/1823ddae-238f-4ab5-86ab-6d21df2fdad3

Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial

Autor: Frits H.A.F. de Man, Job van der Palen, Hanim Sen, K. Gert van Houwelingen, J. (Hans) W. Louwerenburg, Salah A.M. Saïd, Gerard C.M. Linssen, Martin G. Stoel, Clemens von Birgelen, Mounir W.Z. Basalus, Miep A.W.J. Kleijne, Kenneth Tandjung

Publikováno v: Catheterization and cardiovascular interventions, 82(3), 396-405. Wiley-Liss Inc.

Background: Women are underrepresented in clinical research, and few data are available from randomized head-to-head comparisons of second-generation drug-eluting stents (DES) in female patients. Aim of this study was to assess safety and efficacy of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fba846004d9e09700b1de0e4d9c7799e
https://research.utwente.nl/en/publications/513b59d9-3056-4387-92e2-3646eba4e05c

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

Autor: J. Dawn Abbott, R Michael Kirchner

Publikováno v: Vascular Health and Risk Management
Vascular Health and Risk Management, Vol 2009, Iss default, Pp 1089-1097 (2009)

R Michael Kirchner, J Dawn AbbottDepartment of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, RI, USAAbstract: Drug-eluting stents (DES) have had a major impact in interventional cardiology. Compared to bare metal stents, they s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f454bb3685d791814440ac3d054eb89
https://pubmed.ncbi.nlm.nih.gov/20057901